ClinConnect ClinConnect Logo
Search / Trial NCT06646302

The Effect of Different Sound Stimulation on The Residual Inhibition of Tinnitus

Launched by EYE & ENT HOSPITAL OF FUDAN UNIVERSITY · Oct 15, 2024

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

Tinnitus Residual Inhibition

ClinConnect Summary

This clinical trial is studying how different types of sound can affect tinnitus, which is a condition where people hear ringing or other noises in their ears that aren't caused by external sounds. The researchers want to find out if using specific sounds—like noise that matches the frequency of the tinnitus or low-frequency bursts—can help reduce the perception of tinnitus for patients. During the study, participants will try out both types of sound stimulation to see which one works better for them.

To be eligible for this trial, participants need to be adults between the ages of 18 and 70 who experience subjective tinnitus, meaning they hear sounds that others cannot. They should have either one ear affected or both ears with the same tone. It's important that they can communicate in Mandarin or have someone help them. Participants will be asked to cooperate with the study requirements and sign a consent form. If you're considering joining, you'll be part of a supportive environment focused on finding ways to manage tinnitus better, and your feedback will help in understanding how sound can impact this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adults aged between 18 and 70 years old.
  • 2. Subjective tinnitus.
  • 3. Unilateral tinnitus or bilateral tinnitus of the same pitch.
  • 4. Can communicate in Mandarin or with the help of an agent.
  • 5. 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear.
  • 6. Subjects or their legal representatives can understand the purpose of the study, voluntarily participate and can cooperate in completing the experiment according to the instructions, and sign the informed consent form.
  • Exclusion Criteria:
  • 1. Vascular pulsatile tinnitus or objective tinnitus.
  • 2. Bilateral tinnitus with different tones.
  • 3. Patients with significant health problems that interfere with or prevent participation in the experiment or cooperation with follow-up visits.
  • 4. Patients with severe auditory hypersensitivity and psychiatric disorders such as severe anxiety and depression;
  • 5. Currently participating in other research programs that may affect tinnitus.
  • 6. Patients who, in the opinion of the investigator, are not suitable for participation in this clinical trial.

About Eye & Ent Hospital Of Fudan University

The Eye & ENT Hospital of Fudan University is a leading clinical research institution dedicated to advancing the fields of ophthalmology and otolaryngology. With a commitment to innovative medical practices and patient-centered care, the hospital integrates cutting-edge research with clinical expertise to conduct comprehensive clinical trials. Leveraging a multidisciplinary approach, the institution aims to enhance treatment modalities and improve patient outcomes through rigorous scientific investigation and collaboration with academic and industry partners. Its state-of-the-art facilities and experienced team of professionals position the Eye & ENT Hospital of Fudan University as a pivotal contributor to medical advancements in eye and ear, nose, and throat health.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Huawei Li, PhD

Principal Investigator

Eye and ENT Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported